Capstone Investment Advisors
ASXC

Capstone Investment Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Capstone Investment Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,479
Closed -$106K – 1913
2021
Q1 		$106K Buy
+32,479
New +$118K ﹤0.01% 1517
2018
Q3 		– Sell
-11,538
Closed -$654K – 1355
2018
Q2 		$654K Buy
+11,538
New +$420K 0.01% 457

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capstone Investment Advisors's ASXC Position: Q2 2021 in Review

Capstone Investment Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2021, closing a stake of 32,479 shares — an estimated $106K sold.

Capstone Investment Advisors first reported a position in ASXC in Q2 2018 and held it in 2 quarters. The position peaked at $654K in Q2 2018. 119 funds tracked by Wall St. Rank hold ASXC as of Q2 2021.

  • Capstone Investment Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 32,479 Asensus Surgical, Inc. shares in Q2 2021, an estimated $106K.
  • Capstone Investment Advisors first reported a position in Asensus Surgical, Inc. in Q2 2018 and held it in 2 quarters.
  • Capstone Investment Advisors's Asensus Surgical, Inc. position peaked at $654K in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2021.

Based on Capstone Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.